Taking a lead with BS10500
Ambitious pharma company seeks to be first in sector to certify to BS10500
A fast-growing pharmaceutical firm wanted to ensure it maintained its reputation as an ethical leader and turned to Interchange for help.
Concordia International Rx UK Ltd (formerly AMCo) was keen to be one of the first pharmaceutical companies to implement the BS10500 standard for anti-corruption management. Interchange consultant Claire Ward, conducted a thorough analysis of their anti-bribery approach against the criteria of BS10500. We found that their systems were already robust and recommended some tweaks and an additional process before guiding them through application for BS10500 certification.
The client achieved BS10500 certification in December 2015 and was the first UK pharmaceutical company to gain BS10500.
“Interchange’s expertise has ensured that we have the most robust compliance processes possible and the accreditation to prove it.”
Robert Sully, general counsel